26.47

1.03% 0.25

Royalty Pharma Plc (RPRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$26.22

Offen:

$26.26

24-Stunden-Volumen:

727.95K

Relative Volume:

0.34

Marktkapitalisierung:

$11.65B

Einnahmen:

$2.24B

Nettoeinkommen (Verlust:

$673.24M

KGV:

235.29

EPS:

0.1125

Netto-Cashflow:

$2.67B

1W Leistung:

+3.56%

1M Leistung:

-4.54%

6M Leistung:

-2.50%

1J Leistung:

-1.89%

1-Tages-Spanne:

$26.23

$26.52

1-Wochen-Bereich:

$25.10

$26.52

52-Wochen-Spanne:

$25.10

$31.66

Royalty Pharma Plc Stock (RPRX) Company Profile

Firmenname

Royalty Pharma Plc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

(212) 883-0200

Adresse

110 EAST 59TH STREET, NEW YORK, NY

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

RPRX's Discussions on Twitter

Vergleichen Sie RPRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RPRX	26.48	11.65B	2.24B	673.24M	2.67B	0.1125
VRTX	447.00	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	739.78	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	590.30	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.57	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.41	24.49B	3.30B	-501.07M	1.03B	11.54

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-03	Herabstufung	UBS	Buy → Neutral
2022-06-14	Fortgesetzt	UBS	Buy
2022-05-13	Eingeleitet	Scotiabank	Sector Outperform
2022-04-27	Eingeleitet	Goldman	Buy
2022-04-14	Hochstufung	JP Morgan	Neutral → Overweight
2022-04-06	Fortgesetzt	Morgan Stanley	Overweight
2021-10-29	Hochstufung	Citigroup	Neutral → Buy
2021-07-30	Eingeleitet	Tigress Financial	Buy
2020-11-09	Hochstufung	UBS	Neutral → Buy
2020-07-14	Eingeleitet	Evercore ISI	In-line
2020-07-13	Eingeleitet	BofA Securities	Buy
2020-07-13	Eingeleitet	Citigroup	Neutral
2020-07-13	Eingeleitet	Cowen	Outperform
2020-07-13	Eingeleitet	Goldman	Neutral
2020-07-13	Eingeleitet	JP Morgan	Neutral
2020-07-13	Eingeleitet	Morgan Stanley	Equal-Weight
2020-07-13	Eingeleitet	SunTrust	Buy
2020-07-13	Eingeleitet	UBS	Neutral

Alle ansehen

Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten

Nov 19, 2024

Royalty Pharma (NASDAQ:RPRX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Nov 19, 2024

Victory Capital Management Inc. Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 19, 2024

Nov 17, 2024

Amalgamated Bank Sells 48,057 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 17, 2024

Nov 16, 2024

Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy + - Seeking Alpha

Nov 16, 2024

Nov 15, 2024

Royalty Pharma stock hits 52-week low at $25.2 amid market shifts - Investing.com India

Nov 15, 2024

Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week LowTime to Sell? - MarketBeat

Nov 15, 2024

Simplify Asset Management Inc. Increases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 15, 2024

Nov 14, 2024

(RPRX) Technical Data - Stock Traders Daily

Nov 14, 2024

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare - The Manila Times

Nov 14, 2024

Royalty Pharma Awards Inaugural Healthcare Prize to Michael Milken for Cancer Research Impact | RPRX Stock News - StockTitan

Nov 14, 2024

3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a Decade - The Motley Fool

Nov 14, 2024

Nov 13, 2024

Ex-Dividend Reminder: Cencora, Royalty Pharma and Brookline Bancorp - Nasdaq

Nov 13, 2024

Solid Earnings May Not Tell The Whole Story For Royalty Pharma (NASDAQ:RPRX) - Simply Wall St

Nov 13, 2024

Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues - Yahoo Finance

Nov 13, 2024

Syndax shares slide despite pivotal trial success - The Pharma Letter

Nov 13, 2024

Nov 12, 2024

New South Capital Management Inc. Has $69.77 Million Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 12, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 12, 2024

Los Angeles Capital Management LLC Lowers Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Van ECK Associates Corp Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 11, 2024

Nov 10, 2024

Royalty Pharma Q3 2024 Earnings Preview - MSN

Nov 10, 2024

Summit Global Investments Purchases New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Nov 10, 2024

Nov 09, 2024

Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Executive Wealth Management LLC - MarketBeat

Nov 09, 2024

Royalty Pharma Stock: Massive Opportunity Ahead (NASDAQ:RPRX) - Seeking Alpha

Nov 09, 2024

Nov 08, 2024

Morgan Stanley's Strategic Reduction in Royalty Pharma PLC Holdi - GuruFocus.com

Nov 08, 2024

Nov 07, 2024

Royalty Pharma plc (NASDAQ:RPRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million - The Manila Times

Nov 07, 2024